FT Cboe Vest Nasdaq-100 Buffer ETF – March
FT Cboe Vest Nasdaq-100 Buffer ETF – March Fundamental Analysis
FT Cboe Vest Nasdaq-100 Buffer ETF – March (QMAR) shows weak financial fundamentals with a PE ratio of 33.22, profit margin of 0.00%, and ROE of 0.00%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 25.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze QMAR's fundamental strength across five key dimensions:
Efficiency Score
WeakQMAR struggles to generate sufficient returns from assets.
Valuation Score
WeakQMAR trades at a premium to fair value.
Growth Score
ModerateQMAR shows steady but slowing expansion.
Financial Health Score
ModerateQMAR shows balanced financial health with some risks.
Profitability Score
WeakQMAR struggles to sustain strong margins.
Key Financial Metrics
Is QMAR Expensive or Cheap?
P/E Ratio
QMAR trades at 33.22 times earnings. This suggests a premium valuation.
Debt/Equity
FT Cboe Vest Nasdaq-100 Buffer ETF – March has a debt-to-equity ratio of 0.00, indicating its leverage.
How Well Does QMAR Make Money?
Net Profit Margin
For every $100 in sales, FT Cboe Vest Nasdaq-100 Buffer ETF – March keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.00 in profit for every $100 of shareholder equity.
ROA
FT Cboe Vest Nasdaq-100 Buffer ETF – March generates $0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $0.00 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
N/A
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
N/A
vs 25 benchmark
P/B Ratio
Price to book value ratio
N/A
vs 25 benchmark
P/S Ratio
Price to sales ratio
N/A
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.00
vs 25 benchmark
ROA
Return on assets percentage
0.00
vs 25 benchmark
ROCE
Return on capital employed
0.00
vs 25 benchmark
How QMAR Stacks Against Its Sector Peers
| Metric | QMAR Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | N/A | 18.96 | N/A |
| ROE | 0.00% | 797.00% | Weak |
| Net Margin | 0.00% | -7699.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 2.38 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 560.28 | Weak Liquidity |
| ROA | 0.00% | -23967.00% (disorted) | Weak |
QMAR outperforms its industry in 1 out of 5 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews FT Cboe Vest Nasdaq-100 Buffer ETF – March's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical